E-learning and LSI National Credentialing Register
The latest developments from within the NHS – specifically selected for industry.
The Independent Medicines and Medical Devices Safety Review has published a damming report which highlights the inadequate measures to reduce the risk of avoidable harm from medicines and medical devices that are currently in place across the healthcare system.
The Independent Medicines and Medical Devices Safety Review has published its damming report of the “disjointed, siloed, unresponsive and defensive” healthcare system.
Government plans to radically restructure the NHS, in order to regain more direct control over its day-to-day running, have been met with widespread concern.
The Government has announced an extra £3bn to help the NHS to prepare for a potential second wave of Covid-19 this winter and clear the backlog of patients that are waiting for treatment as a result of the pandemic.
NHS Digital has published the NHS combined performance figures, which paint a dismal picture of an NHS under immense pressure.
Prime Minister Boris Johnson has pledged billions of pounds to resuscitate the UK economy and restore the NHS back to health, with £1.5bn announced for the NHS capital budget to pay for hospital maintenance, eradicate mental health dormitories, improve A&E capacity and build new hospitals.
Boris Johnson has pledged billions of pounds to resuscitate the UK economy and restore the NHS back to health, as it works to recover from the Covid-19 pandemic.
NHS services could take years to resume pre-Covid levels, a report by NHS Providers which represents NHS trusts, has found.
Calls from NHS chiefs to extend support from the independent sector, fund extra bed capacity and allow utilisation of nightingale hospitals to cope with rising demand, have been met with stony silence from the Treasury.
The Association of the British Pharmaceutical Industry (ABPI) has launched a public consultation on its “new look, more user friendly” ABPI Code of Practice for 2021.
The UK Government has published its Research and Development (R&D) Roadmap, which sets out the UK’s and ambition for science, research and innovation.
A debate on a clinical registries database, that could help to improve patient safety and outcomes, has begun in Parliament as the UK’s Medicines and Medical Devices Bill has progressed to the upper house.
Disclosure UK has published figures that show industry invested £381.2 million on R&D activities in the UK during 2019, which is up from £377.3million in 2018 and is the third successive year of increasing investment by industry in UK R&D.
For weeks Covid-19 has dominated the headlines. However, while it is still at the forefront of everyone’s minds, there are signs of an attempt to find a “new normal”.
The NHS performance figures have been met with concern over the time it will take to clear the monumental back log of care that has been postponed, cancelled or left undiagnosed due to Covid-19.
NHS England has announced an overwhelming uptake of the Primary Care Network (PCN) enhanced services contract, with 98% of GP practices signing up to the scheme.
From this week, suppliers can register their interest in the world’s first “subscription-style” payment model for antibiotics.
Changes to regulations on medicines supply should be subject to parliamentary scrutiny, the National Pharmacy Association (NPA) has argued in a formal submission to MPs.
The world’s first Covid-19 treatment proven to reduce the risk of death has been approved for use...
The Care Quality Commission has announced that it is due to resume its routine inspections of health and adult social care providers across England in the autumn, subject to the prevalence of Covid-19.
NHS England has published a series of measures which aim to restart the delivery of health and care services, whist ensuring necessary capacity and capability is available to treat future Covid-19 patients.
The Association of the British HealthTech Industry (ABHI) has published guidance for industry professionals that are looking to access NHS premises as healthcare services start to resume.
The National Institute of Health Research (NIHR) has announced plans to restore research that was paused as a result of the Covid-19 pandemic.
The Royal Pharmaceutical Society (RPS) has called for medicines legislation to be amended, so that community pharmacists can make changes to prescriptions in order to minimise unnecessary delays and improve patient access to medicines.
The British Medical Journal has raised concerns over the “deluge of poor quality research that is sabotaging an effective evidence based response to Covid-19”.
The Department of Health and Social Care (DHSC) has announced that it will increase Category M reimbursement prices by £15m in June.
The NHS Confederation and NHS England have launched an expert research centre dedicated exploring the impact of race and ethnicity on people’s health.
Covid-19 has seen the rapid acceleration of innovative approaches to care delivery within the NHS – and healthcare leaders want to ensure that the changes are here to stay.
The NHS Confederation has launched a campaign that calls for a rest in NHS healthcare delivery in order to secure some of the positive changes that have been achieved during Covid-19.
NHS England and NHS Improvement have confirmed their approval of four new integrated care systems (ICS), which together will serve more than 6m people.
Doctors are facing shortages of vital drugs, gases and therapeutics, a survey by the British Medical Association has found.
NHS England has explained to primary care providers the detail behind its highly contentious plans to bring forward elements of the Enhanced Health in Care Homes (EHCHs) model of care from October to May 2020.
Business Secretary Alok Sharma has announced a further £84m to help support researchers develop a Covid-19 vaccine.
The National Institute for Health and Care Excellence has announced plans to work alongside a number of international organisations to share knowledge, identify treatments and develop guidance to support the global effort against Covid-19.
Over 40 countries have pledged a total of £6.5bn to go towards a global effort to development a Covid-19 vaccine and research into its diagnosis and treatment.
The Department of Health and Social Care (DHSC) has announced a £600m care home support package that aims to help reduce the spread of Covid-19 in residential settings.
The Medicines and Healthcare products Regulatory Agency (MHRA) has launched a dedicated Yellow Card reporting site, so that concerns over healthcare products that are being used to treat Covid-19 can be easily reported.
From rapid product development to healthcare delivery, Covid-19 has unleashed innovation across the service at breath-taking speed.
Sir Simon Stevens and Amanda Pritchard have written to organisations across the NHS to set out the operating environment and approach that will be taken as we enter into the second phase of the NHS’s response to Covid-19.
The business secretary, Alok Sharma, has announced the creation of a new taskforce that has been set up to rapidly develop and manufacture a coronavirus vaccine.
Covid-19 treatments could be fast-tracked through a new national clinical trial initiative that aims to accelerate the development of new drugs for patients hospitalised with the illness, in order to reduce the time taken to set up clinical studies for new therapies from months to weeks.
Global leaders have pledged to accelerate cooperation on a coronavirus vaccine and to share research, treatment and medicines across the globe during a virtual World Health Organisation meeting.
An antibody blood test for Covid-19, which claims to be 99% accurate, has been certified for use by the European Union...
The Government has announced that it will wipe the £13.4bn debt that is owed by NHS trusts, whilst also pledging to increase the Covid-19 response fund for the NHS and public services to £14bn in a bid to support the pandemic effort.
The Government has announced that it will wipe the £13.4bn debt that is owed by NHS trusts, whilst also pledging to increase the Covid-19 response fund for the NHS and public services to £14bn.
The UK government is channelling efforts to find treatments for Covid-19 on repurposing existing medication, the UK Health Secretary has said.
The Department of Health and Social Care (DHSC) and the Medicines and Healthcare products Regulatory Agency (MHRA) have announced that an additional 52 medicines can no longer be parallel exported from the UK.
Covid-19 is changing the face of healthcare delivery, acting as a catalyst for innovation and forcing into fruition many of the aims and ambitions that were set out in the NHS Long-term plan (LTP).
The National Institute for Health and Care Excellence has published several rapid response guidelines to the Covid-19 pandemic which aim to support practitioners provide the best possible care to patients.
The exceptional circumstances of Covid-19 continue to dominate the headlines and has filtered into every aspect of healthcare delivery and the life sciences industry
The government's Mandate to NHS England and NHS Improvement has been published for 2020 to 2021, setting out the objectives and budgets for the year ahead.
The impact of Covid-19 has been widespread, with the Medicines and Healthcare products Regulatory Agency (MHRA) announcing several changes to standard practice in order to help support the pandemic effort.
More than 80 medicines used to treat patients in intensive care units have been banned from parallel export from the UK, the government has announced.
What money is available for Covid-19?
The pace of change and pressure facing the NHS is representative of nothing that has been seen before. Covid-19 has bulldozed into the front and centre of everyone’s lives – and the ramifications will be widespread.
NHS England has implemented a series of measures that aim to help the NHS cope under the ‘intense pressure’ of the ‘rapidly increasing’ Covid-19 pandemic.
Simply get in touch and we will endeavour to answer your questions.
Sign in below if you have an existing account
Register for account
Please register for an account if you have never held a MIA card before
Please enter your email address